Position in EXEL
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$19,560,339
+$2,606,009 QoQ
Shares Held
359,499
-9.1% QoQ
Ownership
0.145%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#92
of 756 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 65%
Shared 0%
None 35%
Common Shares in EXEL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Legal & General Group Plc holds $3,299,239,490 across 292 Biotechnology names. EXEL ranks #22 (0.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,870,015 | $928,892,550 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
759,971 | $473,872,316 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
924,561 | $278,320,596 | |
| 4 | RPRX |
Royalty Pharma plc
|
3,800,504 | $213,094,258 | |
| 5 | INCY |
Incyte Corp
|
1,605,980 | $182,053,892 | |
| 6 | ARGX |
Argenx SE
|
177,164 | $164,367,443 | |
| 7 | INSM |
INSMED Inc
|
826,431 | $88,114,072 | |
| 8 | RVMD |
Revolution Medicines, Inc.
|
381,366 | $71,422,223 |
All Filings in EXEL
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $19,560,339 | 359,499 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $16,954,330 | 395,298 | Shares | Defined | 2026-05-08 | |
| 2025-12-31 | $19,015,995 | 433,858 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $22,483,718 | 544,400 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $25,647,241 | 581,834 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $21,502,428 | 582,406 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $19,182,730 | 576,058 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $14,993,727 | 577,793 | Shares | Defined | 2025-02-28 | |
| 2024-06-30 | $13,374,794 | 595,229 | Shares | Defined | 2025-05-29 | |
| 2024-03-31 | $16,018,983 | 675,052 | Shares | Defined | 2025-05-29 | |
| 2023-12-31 | $17,533,499 | 730,867 | Shares | Defined | 2025-05-29 | |
| 2023-09-30 | $16,398,686 | 750,512 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $14,843,347 | 776,732 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $15,691,295 | 808,413 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $12,542,300 | 781,939 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $12,091,255 | 771,126 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $15,993,111 | 768,161 | Shares | Defined | 2022-08-22 | |
| 2022-03-31 | $16,031,475 | 707,167 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $12,734,998 | 696,663 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $15,005,319 | 709,807 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $11,969,319 | 656,933 | Shares | Defined | 2021-08-12 | |
| 2021-03-31 | $16,212,345 | 717,678 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $14,149,188 | 704,992 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $17,729,794 | 725,145 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $16,802,341 | 707,765 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $7,598,307 | 441,249 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||